Literature DB >> 32755591

Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1.

Matthew Bratkowski1, Tian Xie2, Desiree A Thayer1, Shradha Lad1, Prakhyat Mathur1, Yu-San Yang1, Gregory Danko1, Thomas C Burdett1, Jean Danao1, Aaron Cantor1, Jennifer A Kozak3, Sean P Brown3, Xiaochen Bai2, Shilpa Sambashivan4.   

Abstract

The NADase SARM1 is a central switch in injury-activated axon degeneration, an early hallmark of many neurological diseases. Here, we present cryo-electron microscopy (cryo-EM) structures of autoinhibited (3.3 Å) and active SARM1 (6.8 Å) and provide mechanistic insight into the tight regulation of SARM1's function by the local metabolic environment. Although both states retain an octameric core, the defining feature of the autoinhibited state is a lock between the autoinhibitory Armadillo/HEAT motif (ARM) and catalytic Toll/interleukin-1 receptor (TIR) domains, which traps SARM1 in an inactive state. Mutations that break this lock activate SARM1, resulting in catastrophic neuronal death. Notably, the mutants cannot be further activated by the endogenous activator nicotinamide mononucleotide (NMN), and active SARM1 is product inhibited by Nicotinamide (NAM), highlighting SARM1's functional dependence on key metabolites in the NAD salvage pathway. Our studies provide a molecular understanding of SARM1's transition from an autoinhibited to an injury-activated state and lay the foundation for future SARM1-based therapies to treat axonopathies.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NAD hydrolase; NAM; NMN; SARM1; autoinhibition; axon; axonopathies; cryo-EM

Mesh:

Substances:

Year:  2020        PMID: 32755591     DOI: 10.1016/j.celrep.2020.107999

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  30 in total

Review 1.  SARM1 can be a potential therapeutic target for spinal cord injury.

Authors:  Qicheng Lu; Benson O A Botchway; Yong Zhang; Tian Jin; Xuehong Liu
Journal:  Cell Mol Life Sci       Date:  2022-02-28       Impact factor: 9.261

2.  Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain.

Authors:  Hannah C Feldman; Elisa Merlini; Carlos Guijas; Kristen E DeMeester; Evert Njomen; Ellen M Kozina; Minoru Yokoyama; Ekaterina Vinogradova; Holly T Reardon; Bruno Melillo; Stuart L Schreiber; Andrea Loreto; Jacqueline L Blankman; Benjamin F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-22       Impact factor: 12.779

3.  The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative SARM1.

Authors:  Yuefeng Jiang; Tingting Liu; Chia-Hsueh Lee; Qing Chang; Jing Yang; Zhe Zhang
Journal:  Nature       Date:  2020-10-14       Impact factor: 49.962

4.  SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration.

Authors:  Matthew D Figley; Weixi Gu; Jeffrey D Nanson; Yun Shi; Yo Sasaki; Katie Cunnea; Alpeshkumar K Malde; Xinying Jia; Zhenyao Luo; Forhad K Saikot; Tamim Mosaiab; Veronika Masic; Stephanie Holt; Lauren Hartley-Tassell; Helen Y McGuinness; Mohammad K Manik; Todd Bosanac; Michael J Landsberg; Philip S Kerry; Mehdi Mobli; Robert O Hughes; Jeffrey Milbrandt; Bostjan Kobe; Aaron DiAntonio; Thomas Ve
Journal:  Neuron       Date:  2021-03-02       Impact factor: 17.173

5.  Injury-Induced Inhibition of Bystander Neurons Requires dSarm and Signaling from Glia.

Authors:  Jiun-Min Hsu; Yunsik Kang; Megan M Corty; Danielle Mathieson; Owen M Peters; Marc R Freeman
Journal:  Neuron       Date:  2020-12-08       Impact factor: 17.173

6.  Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures.

Authors:  Donald V Bradshaw; Andrew K Knutsen; Alexandru Korotcov; Genevieve M Sullivan; Kryslaine L Radomski; Bernard J Dardzinski; Xiaomei Zi; Dennis P McDaniel; Regina C Armstrong
Journal:  Acta Neuropathol Commun       Date:  2021-05-17       Impact factor: 7.801

Review 7.  A Novel NAD Signaling Mechanism in Axon Degeneration and its Relationship to Innate Immunity.

Authors:  Eleanor L Hopkins; Weixi Gu; Bostjan Kobe; Michael P Coleman
Journal:  Front Mol Biosci       Date:  2021-07-08

Review 8.  SARM1 signaling mechanisms in the injured nervous system.

Authors:  Shilpa Sambashivan; Marc R Freeman
Journal:  Curr Opin Neurobiol       Date:  2021-06-25       Impact factor: 7.070

Review 9.  Evolving concepts in NAD+ metabolism.

Authors:  Claudia C S Chini; Julianna D Zeidler; Sonu Kashyap; Gina Warner; Eduardo Nunes Chini
Journal:  Cell Metab       Date:  2021-04-29       Impact factor: 31.373

10.  A phase transition enhances the catalytic activity of SARM1, an NAD+ glycohydrolase involved in neurodegeneration.

Authors:  Heather S Loring; Victoria L Czech; Janneke D Icso; Lauren O'Connor; Sangram S Parelkar; Alexandra B Byrne; Paul R Thompson
Journal:  Elife       Date:  2021-06-29       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.